BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4656 related articles for article (PubMed ID: 23850509)

  • 1. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.
    Jayaraj RL; Azimullah S; Beiram R
    Saudi J Biol Sci; 2020 Feb; 27(2):736-750. PubMed ID: 32210695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    Lynn J; Park M; Ogunwale C; Acquaah-Mensah GK
    J Alzheimers Dis; 2022; 85(2):485-501. PubMed ID: 34842187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML; Soulage CO
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not.
    Sang S; Pan X; Chen Z; Zeng F; Pan S; Liu H; Jin L; Fei G; Wang C; Ren S; Jiao F; Bao W; Zhou W; Guan Y; Zhang Y; Shi H; Wang Y; Yu X; Wang Y; Zhong C
    Alzheimers Res Ther; 2018 Mar; 10(1):26. PubMed ID: 29490669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular links between Alzheimer's disease and diabetes mellitus.
    Yang Y; Song W
    Neuroscience; 2013 Oct; 250():140-50. PubMed ID: 23867771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen: a master regulator of bioenergetic systems in the brain and body.
    Rettberg JR; Yao J; Brinton RD
    Front Neuroendocrinol; 2014 Jan; 35(1):8-30. PubMed ID: 23994581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease.
    Mastrogiacoma F; Bettendorff L; Grisar T; Kish SJ
    Ann Neurol; 1996 May; 39(5):585-91. PubMed ID: 8619543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway.
    Chen C; Li XH; Tu Y; Sun HT; Liang HQ; Cheng SX; Zhang S
    Neuroscience; 2014 Jan; 257():1-10. PubMed ID: 24188791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
    Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
    FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
    Srikanth V; Maczurek A; Phan T; Steele M; Westcott B; Juskiw D; Münch G
    Neurobiol Aging; 2011 May; 32(5):763-77. PubMed ID: 19464758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease.
    Héroux M; Raghavendra Rao VL; Lavoie J; Richardson JS; Butterworth RF
    Metab Brain Dis; 1996 Mar; 11(1):81-8. PubMed ID: 8815392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 233.